Chiu Hsien-Jane, Sun Cheuk-Kwan, Fan Hsin-Yi, Tzang Ruu-Fen, Wang Ming-Yu, Cheng Ying-Chih, Cheng Yu-Shian, Yeh Pin-Yang, Chung Weilun
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Taoyuan, Taiwan.
Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Child Adolesc Psychiatry Ment Health. 2022 Dec 19;16(1):104. doi: 10.1186/s13034-022-00543-1.
The efficacy of surface electroencephalographic neurofeedback (EEG-NF) for improving attentional performance assessed by laboratory measures in patients with attention-deficit/hyperactivity disorder (ADHD) remains unclear.
Following the PRISMA guidelines, the PubMed, Embase, ClinicalKey, Cochrane CENTRAL, ScienceDirect, Web of Science, and ClinicalTrials.gov databases were systematically searched for randomized controlled trials on the efficacy of surface EEG-NF against ADHD focusing on attentional performance evaluated by laboratory measures from inception to January 2022.
Fourteen eligible studies were analyzed. Of the 718 participants involved, 429 diagnosed with ADHD received EEG-NF treatment. Significant improvement in attentional performance in ADHD subjects receiving EEG-NF was noted compared to their comparators (p < 0.01). Besides, there was a significant EEG-NF-associated beneficial effect on sustained attention (Hedges' g = 0.32, p < 0.01), whereas the impact on selective attention (p = 0.57) and working memory (p = 0.59) was limited. Moreover, protocol including beta wave enhancement was superior to that only focusing on reducing theta/beta ratio or modulation of slow cortical potential. Subgroup analyses showed that three sessions per week of EEG-NF produced the best effect, while the efficacy of surface EEG-NF was much poorer (Hedges' g = 0.05) when only studies that blinded their participants from knowledge of treatment allocation were included. No significant difference was noted in the improvement of attentional performance 6-12 months after EEG-NF intervention (n = 3, p = 0.42).
Our results demonstrated the satisfactory effectiveness of surface EEG-NF for improving sustained attention, especially when beta wave enhancement was included, despite its failure to sustain a long-term effect. Further large-scale trials are warranted to support our findings.
对于注意缺陷多动障碍(ADHD)患者,通过实验室测量评估,表面脑电图神经反馈(EEG-NF)改善注意力表现的疗效仍不明确。
按照PRISMA指南,系统检索了PubMed、Embase、ClinicalKey、Cochrane CENTRAL、ScienceDirect、Web of Science和ClinicalTrials.gov数据库,以查找关于表面EEG-NF治疗ADHD疗效的随机对照试验,重点关注从开始到2022年1月通过实验室测量评估的注意力表现。
分析了14项符合条件的研究。在涉及的718名参与者中,429名被诊断为ADHD的患者接受了EEG-NF治疗。与对照组相比,接受EEG-NF治疗的ADHD受试者的注意力表现有显著改善(p<0.01)。此外,EEG-NF对持续注意力有显著的有益影响(Hedges' g=0.32,p<0.01),而对选择性注意力(p=0.57)和工作记忆(p=0.59)的影响有限。此外,包括β波增强的方案优于仅专注于降低θ/β比值或调节慢皮层电位的方案。亚组分析表明,每周进行三次EEG-NF产生的效果最佳,而仅纳入对参与者隐瞒治疗分配信息的研究时,表面EEG-NF的疗效要差得多(Hedges' g=0.05)。EEG-NF干预6至12个月后,注意力表现的改善没有显著差异(n=3,p=0.42)。
我们的结果表明,表面EEG-NF在改善持续注意力方面具有令人满意的效果,尤其是当包括β波增强时,尽管其未能维持长期效果。需要进一步的大规模试验来支持我们的发现。